Bruxelles, le 21.11.2014 C(2014)9042 (final) DÉCISION D'EXÉCUTION DE LA COMMISSION du 21.11.2014 concernant le transfert de l
PRODUCT MONOGRAPH PrTEVA-REPAGLINIDE (repaglinide) 0.5 mg, 1 mg and 2 mg tablets Teva Standard Oral Antidiabetic Agent Teva Can
![Molecules | Free Full-Text | Determination of Chemical Stability of Two Oral Antidiabetics, Metformin and Repaglinide in the Solid State and Solutions Using LC-UV, LC-MS, and FT-IR Methods Molecules | Free Full-Text | Determination of Chemical Stability of Two Oral Antidiabetics, Metformin and Repaglinide in the Solid State and Solutions Using LC-UV, LC-MS, and FT-IR Methods](https://pub.mdpi-res.com/molecules/molecules-24-04430/article_deploy/html/images/molecules-24-04430-ag-550.jpg?1577838907)